Use of adenosine A1 and/or dual A1/A2b agonists for production of medicaments for treating diseases

Details for Australian Patent Application No. 2007222736 (hide)

Owner Bayer HealthCare AG

Inventors Wuttke, Martina; Bischoff, Hilmar; Krahn, Thomas; Albrecht-Kupper, Barbara; Diedrichs, Nicole; Hubsch, Walter; Nell, Peter

Agent Davies Collison Cave

Pub. Number AU-A-2007222736

PCT Pub. Number WO2007/101531

Priority 10 2006 009 813.7 01.03.06 DE

Filing date 16 February 2007

Wipo publication date 13 September 2007

International Classifications

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/4439 (2006.01)

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

Event Publications

25 September 2008 PCT application entered the National Phase

  PCT publication WO2007/101531 Priority application(s): WO2007/101531

10 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007222754-Stabilization of iodine-containing biocides by means of special azole compounds

2007222732-Personal care compositions containing quaternary ammonium trihydroxy substituted dipropyl ether